Curriculum vitae peter J. Quesenberry, M. D

LECTURES AND PRESENTATIONS (since 1993)

• 
  "In-vitro and in-vivo studies of stromal niches" presented at Stem Cell meeting. Santa Fe, NM. May 1993.
  
• 
  "Hematopoietic growth factors in Cancer Chemotherapy: Are we asking the right questions?" Presented at Medical Grand Rounds. UMASS, June 1993.
  
• 
  "Niche modulation and control of hematopoiesis" Invited speaker. ASH Hematology/Oncology Research Seminar. Brigham & Women's Hospital. September 1993.
  
• 
  "Appropriate and inappropriate uses of hematopoietic growth factors" presented at Current Approaches in Cancer Therapy: A Case Management Seminar. Worcester, MA. October 1993.
  
• 
  "Cytokines in Bone Marrow Transplantation" co-chairman of workshop. Keystone Symposium on Advances & Controversies in Bone Marrow Transplantation, Keystone, Colorado. February 1994.
  
• 
  "Role of hematopoietic cytokines in clinical medicine" Visiting professorship. St. Elizabeth's Hospital, Boston, MA. March 1994.
  
• 
  "Hemotherapy" Plenary speaker at the XXV meeting of the International Society of Hematology. Cancun, Mexico. April 1994.
  
• 
  Guest speaker - Senior Scholar's Program. UMASS. May 1994.
  
• 
  "Translational Research: Challenge of the 90's". Keynote speaker at the 1994 Summer Research Programs. UMASS. August 1994.
  
• 
  "Molecular mechanisms mediating stem cell activity". Presented at Seminars in Cell Biology Lecture. UMASS Cell Biology. September 1994.
  
• 
  "Hematopoietic stem cell: Proliferative phenotype". Presented at the Cell Cycle and Growth Control meeting. UMASS Cancer Center. October 1994.
  
• 
  "Cytokines in Clinical Therapy" Invited speaker for the Brigham & Women's Hospital/ Harvard Medical School Hematology/Oncology Intensive Review course. Boston, MA. October, 1994.
  
• 
  "Blood Supply: Risks, Perceptions and Prospects for the Future". Presented at the American Association of Blood Banks, ARC. San Diego. November 1994.
  
• 
  "Clinical uses of recombinant growth factors, G-CSF, GM-CSF, & IL-3: Presented at Medical Grand Rounds - Deaconess Hospital, Boston, MA. December 1994.
  
• 
  "Hematopoietic Growth Factors - Use and Misuse in Hematology/Oncology" Presented at "Super Friday" Symposium, Controversies in Hematology. M.D. Anderson Cancer Center, TX. December 1994.
  
• 
  "Growth Factors in Transplants" Presents at the 2nd Symposium on Autotransplants. North American Autologous Bone Marrow Transplant Registry (NAABMTR), Keystone, Colorado. January 1995.
  
• 
  "The Application of Recent Advances in Biotechnology to Medicine" Guest speaker at the Middlesex District Medical Society annual meeting. Lynnfield, MA. February 1995.
  
• 
  Reverse site visit for Program Project. Invited consultant and reviewer. National Heart, Lung & Blood Institute (NHLBI), Bethesda, Maryland. February 1995.
  
• 
  Site visit - Cancer Research Center, Beckman Research Institute, City of Hope. Invited reviewer. Duarte, California. February 1995.
  
• 
  "Hematopoietic stem cell engraftment into normal hosts". Presented at the Weber Seminar Series. University of Utah, Cell Biology & Immunology. April 1995.
  
• 
  Chair - NIH/ HLB grant review. May, 1995.
  
• 
  "Stem Cells: Bone Marrow Transplantation and Gene Therapy". Invited speaker at the President's Cancer Panel. Chicago, Illinois. July, 1995.
  
• 
  Chairman - Scientific Workshop Session. International Society for Experimental Hematology (ISEH) annual meeting. Dusseldorf, Germany. August 1995.
  
• 
  "Marrow Transplantation: The Role of Cytokines and Stem Cell Expansion". Guest speaker at Medical Grand Rounds. Yale University, New Haven, CT. September, 1995.
  
• 
  "Proliferative Status of Engrafting Stem Cells" Invited speaker. Hematopoietic Stem Cell Gene Therapy: Biology & Technology Conference. NIDDK - Rockville, Maryland. September 1995.
  
• 
  "Proliferative Status of Engrafting Stem Cells" Invited speaker. Hematology/Oncology Seminar, University of Pennsylvania. Pittsburgh, PA. October, 1995.
  
• 
  "Stem Cell Expansion and Gene Therapy" Invited speaker. Boston Cancer Research Association, Harvard Medical School. Boston, MA. October, 1995.
  
• 
  Federal Government and Special Emphasis Panel. Invited Chairperson for contract proposals. National Institute of Health (NIH). Bethesda, Maryland. October, 1995.
  
• 
  "Hematopoietic Stem Cell: Proliferative Phenotype" Research discussion - Seminars in Cell Biology. UMASS Medical Center, Worcester, MA. October, 1995.
  
• 
  "Engraftment of Quiescent and Cycling Stem Cells into Normal and Myeloablated Murine Hosts" Presented at the Keystone Symposia on Molecular and Cellular Biology. Taos, New Mexico. February, 1996.
  
• 
  "Marrow Stromal and Cytokine Regulation of Primitive Marrow Stem Cells" Invited speaker. Cellular and Molecular Biology of Mesenchyme Conference. Banbury Center, Cold Spring Harbor Laboratory. Cold Spring Harbor, New York. February 1996.
  
• 
  "Stem Cell Homing; Relationship to the Cell Cycle" Invited speaker. Worcester Foundation Symposium on Metastasis: Cell Biology and Therapy of Invasive Tumors. Shrewsbury, MA. May 4, 1996.
  
• 
  “Engraftment into the nonmyeloablated and myeloablated host: Stem cell phenotype”. Co-Chairman New Avenues Session of the Eighth International Symposium on Autologous Marrow & Blood Transplantation. Arlington, TX, August 19, 1996.
  
• 
  Hematopoietic Inhibitors: Biology,l Role in Cytosuppression, and Pharmacological Modulation. Session Chair. Omni Rosen Hotel, Orland Florida, December 6, 1996.
  
• 
  “Stem Cell Engraftment & Cell Cycle Phenotype”. Invited speaker. XIX Symposium of the International Associate for Compartive Research on Leukemia and Related Diseases. Mannheim/Heidelberg, Geramny. July 13-18, 1997.
  
• 
  “Phenotype Of Hemopoietic Stem Cell” Invited speaker. International Stem Cell Workshop on “Pathophysiology, Diagnostic & Therapeutic Implications of Blood Stem Cells. Schloss Reisensburg, July 9-12, 1997.
  
• 
  “Homing and Engraftment of Lymphohematopoietic Stem Cells”. Keystone Sympoisum. Copper Mountain, Colorado, February 21-26, 1998.
  
• 
  “The phenotype of engrafting marrow-derived stem cells”. Allegheny University. Philadelphia, PA. April 8, 1998.
  
• 
  “Cytokine induced flucutations in hematopoietic stem cell engraftment”. Third Ex vivo workshop, San Diego, CA, April 15, 1998.
  
• 
  “Stem cell engraftment”. 6th International symposium on recent advances in hematopietic stem cell transplantation. San Diego, CA. April 16-18, 1998.
  
• 
  “Transplantation strategies for 2000 and beyond”. Emory University Grand Rounds. May 6, 1998.
  
• 
  Rosario, Orcas Island, Washington May 31-June 3, 1998.
  
• 
  “Hematopoietic stem cell engraftment”. Hematopoietivc Stem Cells II International Symposium & Workshop, University of Tubingen, Meersburg, Germany. July 2-4, 1998.
  
• 
  “Allochimerism: an approach to treatment of cancer and hemoglobinopathies.” Marine Biological Laboratories, Woods Hole, MA. November 8-10, 1998.
  
• 
  “Workshop on stem cell assays”. National Institutes of Health. Besthesda, MD. September 8-9, 1998.
  
• 
  “Cellular Immune Therapy” Leukemia Society of America. Washington, DC. September 26-27, 1998.
  
• 
  “Clinical & Molecular Advances in Blood & Marrow Transplantation”. Yale University, CT. October 15, 1998.
  
• 
  “New opportunities in cancer therapy”. Holiday Inn, Worcester, MA. November 12, 1998.
  
• 
  “New concepts for cellular therapeutics”. Grand Rounds, Allegheny University, Glenolden, PA. January 19, 1999.
  
• 
  “Do we need 'space'^,: Hematopoietic stem cell transplants after non myeloablative conditioning regiments: exploiting the graft vs. trumour effect. EBMT Workshop. Zurich, Switzerland. February 1999.
  
• 
  “Phenotype of hematopoietic stem cells”. What are stem cells? From Embryo to adult tissues. The Banbury Center, Cold Spring Harbor Laboratory. February 21-24, 1999.
  
• 
  “Transplantation in minimally myeloablated hosts”. Leukaemia Research Fund International Research Symposium “New Perspectives in Allogeneic Transplantation”. Royal College of Physicians, London. March 10, 1999.
  
• 
  “Allochimerism as a strategy for Disease Treatment”. Grand Rounds, St. Elizabeth’s Medical Center, Boston, MA. March 24, 1999.
  
• 
  “Stem cell engraftment in minimally treated allogeneic and syngeneic hosts”. 7^th International Symposium “Recent advances in hematopoietic stem cell transplantation.” University of California, San Diego. May 6-8, 1999.
  
• 
  “Strategies for stem cell engraftment in non or minimally ablated hosts”. 5^th International meeting of the Cogent Society. Minneapolis, MN. June 18-20, 1999.
  
• 
  International Soceity of Haematology. Durban, South Africa. September 18-23, 1999.
  
• 
  2^nd Semi-annual Worcester Translational Research Conference. “Bone marrow transplantation for the treatment of autoimmune disease”. Worcester, MA. September 23-25, 1999.
  
• 
  American Society of Hematology, annual meeting. New Orleans. December 3-7, 1999.
  
• 
  “28^th Annual meeting of the International Society for Experimental Hematology”. Monte Carlo, Monaco. July 10-14, 1999.
  
• 
  Veterinary Cancer Society. Woods Hole, MA. November 13-16, 1999.
  
• 
  International Workshop on Non-Myeloablative Stem Cell Transplantation. “NST and Hematopoeitic competition: Stem cell transplantation with neither myeloablation nor immunosuppression in immunocompetent recipients.” St. Lucia, January 27-31, 2000.
  
• 
  Massachusetts General Hospital Immunology Seminar. “Stem Cell Engraftment inNon-or Minimally Treated Hosts: Stem Cell and Host Factors.” Boston, MA. March 16, 2000.
  
• 
  European Group for Blood and Marrow Transplatation. New Perspectives in Allogeneic Transplantation of Hematopoietic Cells. “Stem Cell Engraftment and Tolerance.” April 13 – 14, 2000. Milan, Italy.
  
• 
  American Society for Blood and Marrow Transplantation. 2000 Tandem BMT Meeting. “Stem Cell Engraftment in Non- and Minimally Ablated Syngeneic and Allogeneic Murine Transplant Models.” Anaheim, California. March 28 – April 1, 2000.
  
• 
  8^th Annual International Symposium on Recent Advances in Hematopoietic Stem Cell Transplantation. “Biology of Engraftment of Hematopoietic Stem Cells.” University of Heidelberg. Heidelberg, Germany. May 4-6, 2000.
  
• 
  28^th Annual Scientific Meeting of the International Society for Experimental Hematology. Co-chair, Plenary Symposium IV on “Stem Cell Plasticity.” Tampa, Florida. July 8-11, 2000.
  
• 
  International Conference and Workshop on Hematopoietic Stem Cells. University of Tubingen. Tubingen, Germany. September 14–16, 2000.
  
• 
  "New Stem Cells" Wet Workshop, Leiden University, Leiden, The Netherlands. September 18-19, 2000.
  
• 
  European School of Hematology Chronic Myeloid Leukemia Meeting. Portofino, Italy. September 22–25, 2000.
  
• 
  European Group for Blood and Marrow Transplantation. 3^rd International Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation. Montreux, France. November 2-4, 2000.
  
• 
  Society for Neuroscience Annual Meeting. New Oleans, LA. November 4-9, 2000.
  
• 
  Stem Cell Genomics and Therapeutics Expert Panel. Toronto, Canada. November 13-15, 2000.
  
• 
  The American Society of Hematology Annual Meeting. San Francisco, CA. December 1-5, 2000.
  
• 
  Mass General Conference “Converging Therapies”. Boston, MA, March 18, 2001.
  
• 
  UCSD Stem Cell Transplantation Meeting, San Diego, CA, March 28-April 1, 2001.
  
• 
  Santa Barbara, CA, May 3-6, 2001.
  
• 
  Rhode Island Hospital Fellows Conference, May 31, 2001.
  
• 
  Madrid, Spain, June 6-10, 2001.
  
• 
  Leipzig, Germany, June 10-17, 2001.
  
• 
  Bordeaux, France, June 22-26, 2001.
  
• 
  South Africa, July 1-10, 2001.
  
• 
  Research Facilities Improvement Program Workshop, Washington, DC, July 16-17, 2001.
  
• 
  San Francisco, CA, July 18-21, 2001.
  
• 
  Roger Williams Medical Center, Lecture on Stem Cells, August 17, 2001.
  
• 
  National Human Genome Research Inst., Washington, DC, September 24-26, 2001.
  
• 
  University of Virginia, Charlottesville, Va, September 26 & 27, 2001.
  
• 
  54^th Annual Meeting of AABB, San Antonio, Texas, October 13-17, 2001.
  
• 
  2001 Annual Leadership Conference, Leukemia/Lymphoma Society, October 17-20, 2001, Charlotte, NC.
  
• 
  American Clinical & Climatological Association, The Homestead, Hot Springs, VA, October 21-24, 2001.
  
• 
  5^th International Symposium on “In Utero Stem Cell Transplantation and Gene Therapy”, Reno, Nevada, October 28-31, 2001.
  
• 
  Boston University, Lecture on “The New Stem Cell Biology”, November 7, 2001.
  
• 
  Yale University, Lecture on “The New Stem Cell Biology”, November 28, 2001.
  
• 
  43^rd Annual ASH Meeting, Orlando, Florida, December 7-11, 2001.
  
• 
  New York University, Lecture on “The New Stem Cell Biology”, December 19 & 20, 2001.
  
• 
  NHLB Review, Program Project Review for Dr. Robin W. Briehl, Bethesda, MD, January 10, 2002.
  
• 
  Association of Professors of Medicine, 2002 Annual Meeting, Guest Speaker “The Applicability and Ethical Issues of Stem Cell Research” Plenary Session. San Francisco, CA, February 27-March 2, 2002.
  
• 
  Participated in the Roger Williams Medical Center “Ask The Doctor” segment and the Economic Outlook Luncheon at the Business Expo, RI Convention Center, April 10, 2002.
  

• 
  The California Blood Bank Society and the South Central Association of Blood Banks (SCABB), Las Vegas, NV, Guest Speaker, ”The New Stem Cell Biology”, April 18, 2002.
  

• 
  Rhode Island Hospital, Guest Lecturer at Medical Grand Rounds, “The New Stem Cell Biology”, May 7, 2002.
  

• 
  8^th Annual Meeting of the International Society for Cellular Therapy (ISCT, formerly ISHAGE), Guest Speaker and Chairman, Plenary Session “Stem and Mesenchymal Cells”, Barcelona, Spain, May 25-28, 2002.
  
• 
  Participated in the Roger Williams Medical Center’s “Cancer Survivor’s Day” on June 1, 2002.
  
• 
  American Society of Gene Therapy, Boston, MA, Guest Speaker & Chair of Plenary Session on “Hematopoietic – Improving Stem Cell Transduction”, June 5-9, 2002.
  
• 
  Leucadia National Corporation, Stem Cell Therapy and Autoimmune Diseases Conference, Guest Speaker “Hematopoietic Stem Cells – Identity and Plasticity”, Snowbird, Utah, June 6-8, 2002.
  
• 
  Lecture on Stem Cell Plasticity at the Medical School of the Catholic University of Louvain in Brussels, June 11, 2002.
  
• 
  St. Elizabeth’s Medical Center, Boston, MA, Guest Lecturer, “Stem Cell Plasticity”, June 19, 2002.
  
• 
  Baltic Stem Cell Conference 2002, “Stem Cells in Tissue Regeneration”, University of Rostock, at the Castle of Schlitz which is located between Berlin and Rostock, Germany, June 28-30, 2002.
  
• 
  International Society for Experimental Hematology, Member of Plenary Session “Cord Blood Transplantation”, Montreal, Canada, July 5-9, 2002.
  
• 
  Fred Hutchinson Cancer Research Center, Clinical Sciences Leadership Program, Guest Speaker, Seattle, Washington, July 29, 2002.
  
• 
  New England Conference of Radiologic Technologists, Guest Speaker “The New Stem Cell Biology”, Warwick, RI, September 12, 2002.
  
• 
  NBC10 Health & Fit Expo, RI Convention Center, “Ask the Doctor” segment, September 14, 2002.
  
• 
  International Conference and Workshop on Hematopoietic Stem Cells IV, Guest Speaker “The Shifting Phenotype of the Hematopoietic ‘Early’ Cell”, Tubingen, Germany, September 18-21, 2002.
  
• 
  Providence College Biology Seminar Series, “The New Stem Cell Biology”, Providence, RI, October 10, 2002.
  
• 
  American Clinical and Climatological Association, Annual Meeting, Williamsburg, VA, October 24-27, 2002.
  
• 
  American Association of Blood Banks, Annual Meeting, Guest Speaker, Orlando, Florida, October 27-29, 2002.
  
• 
  Project Medical Education Program, Greene Lounge, Stem Cell Talk, November 19, 2002.
  
• 
  American Society of Experimental Hematology Annual Meeting, December 6-10, 2002.
  

• Roger Williams Medical Center, Medical Grand Rounds, December 17, 2002. “Acute Myelocytic Leukemia”.

• 
  Project Medical Education Tour of Stem Cell Lab, January 24, 2003.
  
• 
  Dana Farber Cancer Center, Boston, MA, February 6, 2003. “Determinants of Syngeneic and Allogeneic Engraftment in Mouse and Man.”
  
• 
  Fondation Merieux, Lyon, France, March 13-14, 2003. In Utero Stem Cell Transplantation and Gene Therapy. “Adult Stem Cell Plasticity.”
  
• 
  Fred Hutchinson Cancer Research Center, Mixed Chimerism Investigators’ Meeting, Seattle, WA, April 3-4, 2003.
  
• 
  New England Dermatological Society Meeting, Newport, RI, April 5, 2003. “Stem Cells coming of Age.”
  
• 
  Roger Williams Medical Center/Westin Hotel, “Challenges in the Era of Stem Cell Plasticity” First Annual Symposium and Wetlab Workshop. April 8-11, 2003. Co-Chair of event.
  
• 
  Roger Williams Medical Center, Board of Trustees Meeting, April 30, 2003. Presentation on Department of Research.
  

• Channel 10 Morning News Show, Providence, RI, May 8, 2003. Interview with Frank Coletta. “Ethical Ramifications of for-profit companies that are developing stem cells to find cures for diseases.”

• 
  Boston Medical Center Hem/Onc Research Roundtable, Boston, MA, May 8, 2003. “The Metaphysics of Stem Cells.”
  
• 
  Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA, May 19-20, 2003. “Stem Cell Engraftment” and “The Metaphysics of Stem Cells.”
  
• 
  International Society of Experimental Hematology Annual Meeting, Paris, France, July 5-9, 2003.
  
• 
  RIH Cancer Grand Rounds, Providence, RI, September 4, 2003.
  
• 
  Leukemia & Lymphoma Society of America, “New Horizons: Advances in the Treatment of Leukemia & Lymphoma”, Roger Williams Park Casino, Providence, RI, September 9, 2003.
  
• 
  University of Louisville, James Graham Brown Cancer Center, Louisville, KY, October 7-8, 2003.
  
• 
  Charles University, Prague, Czech Republic, October 22-26, 2003.
  
• 
  American Association of Blood Banks Annual Meeting, San Diego, CA, November 2-4, 2003.
  
• 
  Leukemia & Lymphoma Society of America, Stem Cell Plasticity Session, Cleveland, Ohio, November 6-8, 2003.
  
• 
  American Society of Hematology, San Diego, CA, December 6-9, 2003 (6 presentations).
  
• 
  Rhode Island Department of Health, Providence, RI, December 17, 2003.
  
• 
  Interview for “Health Matters” RWMC TV Show, Providence, RI, January 9, 2004.
  
• 
  Project Medical Education, Overview of Research and tour of Stem Cell Lab, January 23, 2004.
  
• 
  Taussig Cancer Center, ASH Review, Cleveland, Ohio, January 21, 2004.
  
• 
  Leadership Rhode Island Group – Overview of Research and tour of Stem Cell Lab, February 17, 18, 20, and 23, 2004.
  
• 
  Brown University Pathobiology Graduate Program Lecture, “The Stem Cell Continuum”, February 26, 2004.
  
• 
  Mixed Chimerism Collaborators’ Meeting, Seattle, Washington, March 4 & 5, 2004.
  
• 
  Rhode Island Department of Health, presentation to the Genetics Advisory Committee and Dr. Patricia Nolan, Director of the DOH, March 8, 2004.
  
• 
  Presentation at University of Virginia, Charlottesville, VA, on Stem Cell Techniques, March 11, 2004.
  
• 
  Presentation at COBRE Center for Cancer Research Development Seminar, RIH Claverick Lab, Providence, RI, March 18, 2004.
  
• 
  Overview of Research and tour of Stem Cell Lab for Congressman Patrick Kennedy, April 6, 2004.
  
• 
  Tufts Medical, Department of Anatomy & Cellular Biology Lecture, Boston, MA, April 15, 2004.
  
• 
  Presentation for COBRE group at RWMC, April 21, 2004.
  
• 
  Stem Cell meeting of Grantees, NIH/NHLBI, Bethesda, MD, April 26-28, 2004.
  
• 
  Presentation for Decof family (Adele R. Decof Cancer Center), RWMC, May 13, 2004.
  
• 
  Presentation at the ISAC’s XXII International Congress, Montpellier, France, May 22-27, 2004.
  
• 
  Participant in ISAC tutorial for DakoCytomation, Montpellier, France, May 25, 2004.
  
• 
  American Society of Gene Therapy’s 7^th Annual Meeting presentation, Minneapolis, Minnesota, June 2-6, 2004.
  
• 
  Presentation at the Stem Cell Therapeutics Excellence Centre Conference, Cracow, Poland, June 7 & 8, 2004.
  
• 
  International Society for Experimental Hematology Annual Conference, New Orleans, Louisianna, July 17-21, 2004.
  
• 
  Lecture on Myeloma to RWMC residents/interns/fellows, August 2, 2004.
  
• 
  International Symposium on Hematopoietic Stem Cells V presentation, Tubingen, Germany, September 16-18, 2004.
  
• 
  Lecture at the Lund Strategic Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden, September 20-21, 2004.
  
• 
  Preparatory Meeting for Hemopoiesis & Aging Conference to be held in 2005, Erice, Sicily, October 19-20, 2004.
  
• 
  Mixed Chimerism Collaborators’ Fall Meeting, Seattle, Washington, October 28-29, 2004.
  
• 
  Participation in Planning a meeting of COBRE Principal Investigators meeting, NIH, Bethesda, MD, November 8-9, 2004.
  
• 
  Annual American Society of Hematology meeting, San Diego, CA, December 1-5, 2004.
  
• 
  Fox Chase-Temple BMT Program, Philadelphia, PA, February 2-3, 2005.
  
• 
  Tandem BMT Meetings, Keystone Conference Center, Keystone, Colorado, February 10-14, 2005.
  
• 
  HLB Review, Annapolis, MN, March 10-11, 2005.
  
• 
  31^st Annual Meeting of the European Group for Blood and Marrow Transplantation, Prague, Czech Republic, March 18 – 26, 2005.
  
• 
  Grand Rounds at RIH Pathology Department, Providence, RI, April 7, 2005.
  
• 
  Talk at RIH Orthopedic Research Group, Providence, RI, April 13, 2005.
  
• 
  Talk at UVA, “Basic and Therapeutic Implications of the Stem Cell Continuum”
  

Charlottesville, VA, May 1-3, 2005.

• 
  Talk on stem cells at the dinner reception for National Nurses Week, Providence, RI, May 12, 2005.
  
• 
  Leukemia & Lymphoma Society, 2005 Translational Research Review Subcommittee, New York, NY, May 19-20, 2005.
  
• 
  2^nd International Workshop on Concepts and Mathematical Models of Tissue Stem Cell Organization, Leipzig, Germany, May 24-29, 2005.
  
• 
  Talk regarding stem cells for blood replacement at Brown University, Providence, RI, June 14, 2005.
  
• 
  Biomedical Research Council, BMRC Proposal Evaluation, phone review, July 2005.
  
• 
  Idea Meeting, Maine, July 16-19, 2005.
  
• 
  Adult Stem Cells Workshop, Burlington, VT, July 25-26, 2005.
  
• 
  ISEH Annual Meeting, Glasgow, Scotland, July 29-August 3, 2005.
  
• 
  The 2005 Stohlman Scholar Symposium, The Leukemia & Lymphoma Society, Scottsdale, Arizona, September 22-24, 2005.
  
• 
  XXXth World Congress of the International Society of Hematology, Current Perspectives on Stem Cell Biology and Challenges in Clinical Implications, Istanbul, Turkey, September 25 – 28, 2005.
  
• 
  Presentation on stem cells at the VFW Hall in Cranston, RI, October 1, 2005.
  
• 
  Third Annual Meeting of European Stem Cell, Therapeutics Excellence Centre (STEC) & Second Meeting of the Polish Stem Cell Excellence Network, Cracow, Poland, October 5 – 11, 2005.
  
• 
  2005 LLSA Translational Research Program Progress Review Meeting, Manhattan, New York, October 20 - 22, 2005.
  
• 
  6^th Annual Meeting of the DFG Priority Program 1109, “Embryonic and Somatic Stem Cells” together with the Priority Program 1129 “Epigenetics”, Dresden, Germany, October 25-30, 2005.
  
• 
  Non-Canonical Concepts in Stem Cell Biology Conference, Roger Williams Medical Center, Providence, RI, November 10-11, 2005.
  
• 
  Frankel Lab, Exp. Bone Marrow Transplant, Weizmann Institute, Petach Tikva, Israel, November 12 – 18, 2005.
  
• 
  Presentation at the University of Florida, March 22-24, 2006
  
• 
  Department of Hematology/Oncology presentation on Acute Leukemia, RWMC, Providence, RI, March 13, 2006.
  
• 
  Presentation for the Program in Stem Cell Biology and Regenerative Medicine at the University of Florida, Shands Cancer Center, March 22-24, 2006.
  
• 
  Presentation at the AlloStem Workshop being held in Naples on March 30-31, 2006.
  
• 
  Presentation at the Canadian Blood and Marrow Transplant Group meeting on April 24, 2006 in Edmonton, Canada.
  
• 
  Presentation on stem cells at the Clinical Laboratory Science Society of New England Annual Meeting, Salve Regina University, Bristol, RI, May 10. 2006.
  
• 
  Presentation at the Pulmonary Research Seminar Series for the Pulmonary/Critical Care Medicine Division at Brown Medical School, May 16, 2006.
  
• 
  ATS Symposium presentation, San Diego, California, May 21, 2006.
  
• 
  COBRE Symposium, Roger Williams Medical Center, Providence, RI, May 23-24, 2006.
  
• 
  Presentation at the IDeA Symposium in Washington, DC, July 22&23, 2006.
  
• 
  New Concepts in Stem Cell Biology: The Continuum. Oklahoma Medical Research Foundation, Oklahoma City, OK, September 7, 2006.
  
• 
  Presentation on the “Global Continuum Model of Stem Cell Regulation, International Symposium on Hematopoietic Stem Cells VI in Tubingen, Germany, September 14-16, 2006.
  
• 
  Presentation at the Canadian Blood and Marrow Transplantation Group meeting on cell cycle related transdifferentiation into lung cells in Edmonton, Canada, April 21-24, 2006.
  
• 
  West Virginia University School of Medicine, 15^th Annual Palladino Lecture, “Stem Cell Continuum”. Morgantown, W VA, June 15, 2007.
  
• 
  Co-organizer, Molecular Characteristics of Normal and Leukemia Stem Cells Conference, Brazil, Talk Title: The Stem Cell Continuum, July 25-August 4, 2007.
  
• 
  Medical Grand Rounds, RIH, 2007.
  
• 
  Stem Cell RFA Grantees Meeting, NIH, 2007.
  
• 
  ACLS-CNE, Annual American Society for Clinical Laboratory Science Central New England, Microvesicular Alteration of Cell Phenotype, RI Convention Center, 2007.
  
• 
  Jewish Medical Ethics Forum, Controversies in Stem Cell Therapies, 2007.
  
• 
  Yale Hematology Seminar, The Stem Cell Continuum: An Alternate Model of Stem Cell Regulation, 2007.
  
• 
  Nurse Conference, Transplant History and The Basis for Future Advancement, 2007.
  
• 
  Noon Conference at The Miriam Hospital on Anemias, 2007.
  
• 
  GvH GvL Symposium, Targeting Stem Cells, Munich Germany, 2008.
  
• 
  Stem Cells and Leukaemia – Concepts, Models, Simulations, Goldsmiths College, University of London, UK, 2008.
  
• 
  ISSCR abstract/poster presentation, 2008.
  
• 
  ASCO presentation, 2008.
  
• 
  National Cancer Survivor’s Day presentation, 2008.
  
• 
  Mayo Clinic, Cellular Therapy of Malignancies, Rochester, Minnesota, 2009.
  
• 
  Morning Report, Jane Brown, March, 2009.
  
• 
  Experimental Biology Meeting, Stem Cell Session, New Orleans, LA, 2009.
  

GRANTS (current):

1. 7R01 HL073749-05 – “Cell Cycle Related Transdifferentiation into Lung Cells”

PI – Quesenberry, PJ

8/15/03-7/31/09 1,014,800 (direct costs) 1,775,900 (total costs)

UNIVERSITY TEACHING ROLES/HOSPITAL TEACHING ROLES

Leadership of educational programs:

Research Department Seminar Series: Invite speakers, both national and international, to speak on various topics as follows:

• 
  Esmail D. Zanjani, Ph.D., Professor of Animal Biotechnology, Professor of Medicine, University of Nevada, Reno. “In Utero Stem Cell Therapy”.
  
• 
  Edward G. Stopa, MD, Director of Neuropathology, Brown University School of Medicine. “Microvascular Injury, Extracellular Matrix Disruption and Blood-Brain Barrier Failure in Alzheimer’s Disease”.
  
• 
  Angela E. Frimberger, VMD, Diplomate ACVIM (Oncology), Executive Director of American College of Veterinary Internal Medicine Foundation, Clinical Assistant Professor at Tufts University School of Veterinary Medicine, North Grafton, MA, Adjunct Senior Lecturer in Veterinary Oncology, Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand. “Autologous Bone Marrow Transplant-based Treatment of Canine Lymphoma”.
  
• 
  Dr. Daniel G. Wright, Director, Hematopoietic Stem Cell Transplantation Program, Boston University Medical Center, Professor of Medicine and Pathology, Boston University School of Medicine. “Metabolic determinants in the regulation of hematopoietic progenitor cell development”.
  
• 
  Jean-Francois Lambert, MD, Chef de Clinique, Division of Hematology, University of Geneva, Geneva, Switzerland. “NHL: What’s New”.
  
• 
  Professor David Brynmore Thomas, Emeritus Professor of Anatomy and Experimental Pathology in the University of St. Andrews, Chancellors’ Assessor on the Court of the University of St. Andrews. “The Context of Stem Cell Biology”.
  

Teaching in established programs/institutions:
Dr. Quesenberry has also mentored many college and medical students and residents for shorter time frames and has been the P.I. on a successful hematology training grant at the University of Virginia. He has been on the thesis committees of Dr. Sussie Nilsson, Lionel D’Hondt, and Suzanne Micallef. He continues to interact productively with most of his previous students and mentees.
He has maintained a particular focus on mentoring junior investigators, with the most recent including Drs Colvin, Abedi, Moore and Cerny.

• 
  Basmaa Ali – Hospitalist at RWMC who is currently in our Laboratory for research experience. Graduate of University of Illinois with board certification in Internal Medicine.
  
• 
  Babak Robert Bina – Doctor of Osteopathic Medicine. Dr. Quesenberry served as Teaching Physician for one month in our Laboratory for a Graduate Medical Education Elective Rotation November 1-30, 2002.
  
• 
  Michael Barretti – Fourth year student at Touro University College of Osteopathic Medicine performed his Hematology/Oncology rotation from September 16 – October 13, 2002 under the direction of Gerald Colvin, DO and Peter J. Quesenberry, MD.
  
• 
  Jan Cerny – A postdoctoral fellow in our Laboratory who also performed his first rotation as a resident for a research (elective) rotation for the month of July 2003.
  
• 
  Reem Beckerly –University of New England Osteopathic Clinical Clerk in Medicine. Dr. Quesenberry served as Teaching/Attending Physician for Reem from 2/11/02 – 3/22/02.
  
• 
  Imad Bitar – Dr. Quesenberry served as Teaching Physician for Imad during the month of June 2003.
  
• 
  Rajmayur Brahmbhatt – Dr. Quesenberry served as Teaching Physician for Rajmayur during the month of June 2003.
  
• 
  Jaime Cohen – Clinical Clerk from University of New England Osteopathic Medicine. Completed a one-month research rotation with Dr. Quesenberry as her preceptor from 2/11/02 – 3/22/02.
  
• 
  Amanda Demetri – A third year medical student from University of New England College of Osteopathic Medicine in Biddeford, Maine. Dr. Quesenberry served as Teaching/Attending Physician for Amanda from 5/12/03 to 6/20/03.
  
• 
  James Driscoll – A resident at Roger Williams Medical Center. Dr. Quesenberry served as Teaching/Attending Physician for Jim for the month of November 2002.
  
• 
  Hannah Hebert – A resident at Roger Williams Medical Center. Dr. Quesenberry served as Teaching/Attending Physician for Hannah’s elective rotation in Research from 2/1/03 – 2/28/03.
  
• 
  Mudassir Ilyas Malik – A second year intern from the Michael Reese Hospital of Medicine. He completed a one-month research rotation with Dr. Quesenberry in our Laboratory in July 2002.
  
• 
  Diane Paggioli – A Resident at Roger Williams Medical Center. Completed a one-month elective research rotation with Dr. Quesenberry from 1/3/03 – 1/31/03.
  
• 
  Jeffrey Pimentel – A Biology Major at Providence College. He completed an internship in our Laboratory for the Spring Semester of 2002 and also from 12/18/02 – 1/15/03. Upon graduation, he was hired as a Research Assistant by Dr. Quesenberry to work in our Laboratory.
  
• 
  Nathaniel Slater – Clinical Clerk from University of New England Osteopathic Medicine. Completed a one-month research rotation with Dr. Quesenberry as his preceptor from 5/12/03 – 6/20/03.
  

Role model/mentor activities:
Dr. Quesenberry has a long and successful mentoring history. Below is a breakdown of the individuals, their research activities during the mentoring period and their current situation:

Dr. Kenneth Zuckerman (actinomycin and endotoxin effects of erythropoiesis) - Professor of Medicine at University of South Florida.

F. Richard Sullivan (inhibitor T cells in aplastic anemia and diffusion chamber hematopoietic progenitor/stem cells) - Associate Professor of Medicine, Molecular Physiology, and Biophysics at Baylor Medical School.

Dr. Lee Levitt (lithium effects on hematopoiesis and endotoxin effects on hematopoiesis) - Professor of Medicine/Hematology, Stanford Medical School.

Dr. Michael A. Doukas (the effects of lithium on hematopoiesis) - Associate Professor of Medicine and Pharmacy at the University of Kentucky.

H. Scott Boswell (Thy-1 antigen on hematopoietic stem cells and cryopreservation of stem cells) - Professor of Medicine, University of Indiana.

Dr. ZX Song (studies of a stromal derived hematopoietic synergistic factor) - A successful academic in Beijing.

Dr. Y He (study of effect of pertussis toxin on hematopoietic stem cells) – husband of Dr. Song and successful academic in Beijing.

Dr. Gerard Colon-Otero (pertussis effects on hematopoiesis) – Assistant Professor of Medicine, Mayo Medical School, Consultant, Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida.

Dr. F. Marc Stewart (studies of stem cell engraftment into non or minimally myeloablated host mice, and studies of post-5-flurouracil human marrow in clinical transplantation) - Professor of Medicine at the University of Washington.

Dr. Michael Williams (Immunoglobulin gene rearrangements in lymphoma, minimal time in my laboratory, mostly as junior faculty member at the University of Virginia while I was Head of the Division of Hematology/Oncology) - Professor of Medicine at the University of Virginia.

Ian K. McNiece (synergistic stimulation of hematopoietic progenitor cells and isolation of a unique synergistic activity) - Professor of Medicine, Johns Hopkins School of Medicine.

Dr. Stephan Peters (In vitro cytokine effect on murine stem cell engraftment) - Laboratory of Experimental Stem Cell Biology, University of Lubeck, Germany.

Dr. Lionel D’Hondt (effect of 5-FU on hematopoietic stem cells and circadian rhythms of hematopoietic stem cells) - Department of Hematology and Oncology at Centre Hospitalier Notre-Dame et Reine Fabiola in Belgium.

Dr. Sussie Nilsson (homing, cell cycle status, and geographical location of infused murine hematopoietic stem cells, transdifferentiation of marrow stem cells to bone cells in vivo) - Assistant Professor of Medicine, McCallum Cancer Center, Melbourne.

Dr. Hayley Ramshaw (Engraftment of marrow hematopoietic stem cells in nonablated mice, and effects of 5-FU) - Hanson Center for Cancer Research, Adelaide, South Australia.

Dr. Angela Frimberger (membrane phenotype of murine hematopoietic stem cells, and adherence of stem cells in vitro to stromal cells) - Executive Director of the American College of Veterinary Internal Medicine Foundation.

Dr. Gerald Colvin (studies on hematopoiesis in microgravity cultures and the impact of cell cycle transit of hematopoietic differentiation) - Assistant Professor of Medicine, Boston University School of Medicine, appointment pending.

Dr. J.F. Lambert (studies of allochimeric marrow stem cell engraftment in H2 mismatched mice, and studies of allochimeric homing) - Department of Hematology at the University Hospital of Geneva.

Dr. Mehrdad Abedi (marrow cell transdifferentiation to liver cells and allochimerism) - to be appointed Assistant Professor of Medicine, Boston University July 2002.

Dr. Jan Cerny (homing of marrow stem cells) presently a post-doctoral fellow at RWMC.

Dr. Brian Moore (marrow cell conversion to neural cells in brain injury models) post-doctoral fellow at RWMC. He completed a one-year fellowship in Dr. Quesenberry’s Laboratory.

Dr. Jason Aliotta (lung/microvesicles) currently a Pulmonary/Hem/Onc physician at Rhode Island Hospital and Assistant Professor of Medicine at The Warren Alpert Medical School of Brown University and Rhode Island Hospital.